Georgia Statedawgnation.com

Georgia football podcast: Mixed opinions regarding JT Daniels’ outlook ahead of pivotal season

Georgia football is the No. 1 topic every day on DawgNation Daily — the daily podcast for Georgia Bulldogs fans. Catch up on everything happening with UGA athletics with host Brandon Adams and the DawgNation experts as they break down the latest Georgia football recruiting news and discuss coach Kirby Smart’s quest to return the Bulldogs to the top of the SEC. On episode No. 1,496 (Aug. 3, 2021) of the podcast, Georgia fans can hear a discussion about some disagreement within the media about what to expect from UGA quarterback JT Daniels this season.
Picture for Georgia football podcast: Mixed opinions regarding JT Daniels’ outlook ahead of pivotal season

Gold Price Technical Outlook Warns of Looming Death Cross Formation

The price of gold appears to have reversed course following the failed attempt to test the July high ($1834), and the precious metal may continue to give back the rebound from the June low ($1751) as it initiates a fresh series of lower highs and lows. Gold Price Technical Outlook...
Picture for Gold Price Technical Outlook Warns of Looming Death Cross Formation

SolarWinds CEO on his cybersecurity outlook for the year

"The guidance is becoming clearer by the day," SolarWinds CEO Sudhakar Ramakrishna tells Squawk on the Street about public policy guidance around cybersecurity standards. He joins the show to discuss his company's earnings and outlook for the rest of the year.
MarketsPosted by

Outlook Therapeutics Stock Soars on Positive Results for Eye Treatment

Outlook Therapeutics (OTLK) - Get Report climbed Tuesday after the biopharmaceutical company reported positive results for its treatment of neovascular age-related macular degeneration, or wet AMD. Shares of the Iselin, N.J., company were surging 35% to $3.04. Outlook Therapeutics said it saw "positive clinical and highly statistically significant top-line results"...
Medical & Biotechophthalmologytimes.com

Outlook Therapeutics a step closer to FDA approval of bevacizumab-vikg for treatment of wet AMD

Outlook Therapeutics has reported positive efficacy and safety data from Phase 3 NORSE TWO trial of bevacizumab-vikg. Outlook Therapeutics announced positive clinical and highly statistically significant top-line results from its pivotal Phase 3 NORSE TWO safety and efficacy trial evaluating bevacizumab-vikg (ONS-5010, Outlook Therapeutics Inc.) for the treatment of wet age-related macular degeneration (wet AMD).
Financial ReportsPosted by

UK's Taylor Wimpey raises annual outlook, swings to H1 profit

(Reuters) - UK homebuilder Taylor Wimpey Plc on Wednesday joined bigger rivals in forecasting sustained demand in the medium term and returned to a half-year profit as Britain’s housing sector boom stands to outlast the tax holiday period. Britain’s third-largest homebuilder forecast 2021 operating profit of about 820 million pounds...
Michigan StateMaize n Brew

Sammy Faustin’s path to Michigan, outlook for 2021

Maize n Brew’s previews and outlook for each scholarship player continues today with a further look at redshirt junior safety Sammy Faustin. Up to this point, he hasn’t put it all together to find consistent playing time on defense. Is 2021 the year for him?. Let’s take a look at...
Medical & BiotechPhramalive.com

“Outlook” Good as Company’s AMD Drug Shines in Phase III

Topline results from Outlook Therapeutics‘ pivotal Phase III NORSE TWO safety and efficacy trial show the biopharmaceutical company’s ONS-5010/LYTENAVA™ (bevacizumab) significantly improved outcomes in patients with neovascular age-related macular degeneration (wet AMD). Shares in the company climbed more than 30% premarket following the news of the study findings. The late-stage...

CFRA Research Gets on Board These Airline Stocks

CFRA Research is a leading independent research firm; it uses a differentiated proprietary methodology that blends forensic accounting and fundamental equity research. In its flagship newsletter, The Outlook, analyst Colin Scarola reviews two airline stocks that continue to warrant buy ratings. CFRA raises its STARS rating on shares of Delta...

Mirabai Chanu Stands A Chance Of Medal Upgrade? False Story From ANI Goes Viral

Manipur-based Saikhom Mirabai Chanu clinched a silver medal in the 49 kg weightlifting category at the 2020 Tokyo Olympics. The event took place on 24 July where she came second to China's Zhihui Hou. Two days after that, on 26 July, ANI reported that anti-doping authorities would test Hou; if Hou fails the test, Chanu will be upgraded to the gold medal. In the report, ANI stated, "She has been asked to stay in Tokyo, and the test will be done. The test is definitely happening," and quoted "a source in the know of developments." The report was published at noon, 1:18 IST.